# debiosdx.com ## Posts - [Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients](https://debiosdx.com/debios-article/): Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients Date of publication : 2024 Authors: Clos-Sansalvador M, Taco O, Rodríguez-Martínez P, et al.  Background Interstitial fibrosis and tubular atrophy (IFTA) is a critical factor in the prognosis of kidney health. Currently, IFTA quantitation in kidney biopsy samples is crucial for diagnosis and assessing disease severity, but the available non-invasive biomarkers are not satisfactory. Proteomic studies identified urinary vitronectin (VTN) as a potential biomarker for kidney fibrosis. As mass spectrometry techniques are not practical for use in clinical settings, we tested whether […] ## Pages - [Contact Us](https://debiosdx.com/contact-us/): Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form.Name *E-mail *Subject *Message * send message  Contact Info     Debios Diagnostics S.L.     Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona    info@debiosdx.com - [Newsletter](https://debiosdx.com/newsletter/): [newsletter] - [technology](https://debiosdx.com/technology/): innovation efficiency ethics trust Non-Invasive Testing Discover our cutting-edge, non-invasive testing solutions that empower clinicians to diagnose genitourinary diseases with confidence and ease, ensuring a better experience for patients. Our innovative approach reduces complications and enhances early detection, leading to personalized care and improved patient outcomes. Biomarker Discovery Unlock the potential of biomarker discovery with our advanced technologies, helping clinicians identify critical indicators for early diagnosis and effective treatment strategies in genitourinary health. This breakthrough enables personalized patient management, leading to better outcomes and a brighter future for kidney health Personalized Prognostics Experience our personalized prognostics solutions that tailor treatment […] - [Home](https://debiosdx.com/): discover our solution Revolutionizing Genitourinary Disease Diagnostics and Monitoring 1. Enabling early detection for timely and effective treatment decisions. 2. Non-invasive tests for safer, easier, and more equitable diagnosis. 3. Personalized care tailored to each patient’s unique needs. Our Technological approach IVD – Medical devices We develop, validate, and deliver non-invasive, personalized diagnostic and prognostic solutions that enable early detection and guide individualized treatment. Novel biomarker discovery In partnership with international clinical KOLs and institutions, we investigate and identify novel biomarkers that advance the frontiers of non-invasive genitourinary disease diagnostics and monitoring. From the Clinic to the Patient Each test […] - [news](https://debiosdx.com/news/) - [investors](https://debiosdx.com/investors/) - [team](https://debiosdx.com/team/): EMPOWERING CLINICIANS, ENHANCING LIVES Our Commitment to Early Diagnosis and Better Patient Care At the heart of our mission is a passion for improving patient outcomes. We empower healthcare providers with innovative, non-invasive tools for early diagnosis and effective management of genitourinary diseases. Our dedicated R&D team is constantly exploring new frontiers in diagnostics. We believe that better tools lead to better care. By focusing on early detection, we help clinicians personalize treatment plans, fostering trust and improving the overall patient experience. Together, we can make a difference! Our leading team > Marta Clos, PhD.  CTO & co-founder –IVD Technology […] [comment]: # (Generated by Hostinger Tools Plugin)